Ad is loading...
CEMDX
Price
$12.47
Change
-$0.07 (-0.56%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

CEMDX vs RNWFX

Header iconCEMDX vs RNWFX Comparison
Open Charts CEMDX vs RNWFXBanner chart's image
Cullen Emerging Markets High Div Retail
Price$12.47
Change-$0.07 (-0.56%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
CEMDX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CEMDX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEMDX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. CEMDX (918M). CEMDX pays higher dividends than RNWFX: CEMDX (3.81) vs RNWFX (1.51). CEMDX was incepted earlier than RNWFX: CEMDX (12 years) vs RNWFX (23 years). CEMDX is a more actively managed with annual turnover of: 65.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than CEMDX: RNWFX (250) vs CEMDX (1000). CEMDX annual gain was more profitable for investors over the last year : 16.22 vs. RNWFX (11.54). CEMDX return over 5 years is better than : 44.95 vs. RNWFX (17.17).
CEMDXRNWFXCEMDX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD8.3297.099117%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets918M60.9B2%
Annual Yield % from dividends3.811.51253%
Returns for 1 year16.2211.54141%
Returns for 3 years18.54-14.55-127%
Returns for 5 years44.9517.17262%
Returns for 10 years61.7841.00151%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics